期刊文献+

护理干预能够有效控制化疗药物致消化道的毒性反应 被引量:3

Nursing Intervention Could Effectively Control Toxicity Reaction of Digestive Tract Caused by Chemotherapy
原文传递
导出
摘要 本研究将88例接受化疗的肿瘤患者根据随机数字表分为两组,其中,对照组予以常规护理,观察组予以护理干预。对比两组干预后的消化道毒性反应发生情况、症状积分、生活质量及护理满意度之后,发现两组在消化道毒性反应的发生情况及症状积分方面有差异,观察组的不良反应发病率及症状积分低于对照组(p<0.05)。两组干预后的SCL-90量表在躯体化、抑郁、恐惧、敌对和焦虑等5个方面的得分均有差异,观察组低于对照组(p<0.05)。观察组满意度为90.91%,对照组满意度为75.00%,两组在对护理工作的满意度方面有差异,观察组高于对照组(p<0.05)。 In this study, 88 cases of cancer patients treated by chemotherapy were divided into two groups accord- ing to the random number table. Routine nursing care was provided for the control group while observation group received additional nursing interventions. After contrasting the digestive tract toxicity reaction condition, symptom integral, quality of life and nursing satisfaction of two groups after intervention, we found that the digestive tract toxicity reaction condition and symptom integral between the two groups were different. The adverse reactions rate and symptom integral of observation group were obviously lower than those of control group (P〈0.05). After intervention, the Symptom Checklist 90 of two groups was different in five aspects: somatization, depression, fear, hos tility and anxiety. Observation group was obviously lower than that of control group (p〈0.05). The satisfaction of observation group was 90.91% and the satisfaction of the control group was 75%. There were significant differences between the nursing satisfaction of two groups, and the satisfaction in the observation group was significantly higher than that in the control group (p〈0.05).
作者 胡燕
出处 《基因组学与应用生物学》 CAS CSCD 北大核心 2017年第5期1852-1857,共6页 Genomics and Applied Biology
基金 乐山职业技术学院提供项目资助
关键词 护理干预 化疗 消化道毒性反应 Nursing interventions, Chemotherapy, Digestive tract toxicity reaction
  • 相关文献

参考文献5

二级参考文献35

  • 1Noda K,Ikeda M, Taguchi T, et al. Clinical evaluation of YM060 oral preparation in the treatment of nause and vomiting induced by the anticancer drug cisplatin: a phaseIII double-blind comparative study with ondansetron hydrochloride. J New Remed Clin,1996,45:1445-1462.
  • 2Nakamura E, Imasaki H, Takeshige T, et al. Metabolic rate of ramosetron hydrochloride(2): absorption, distribution and excretion after oral administration of 14 C-ramosetron hydrochloride to rats. Xenob Metab Distrib, 1995,10:808-818.
  • 3郝玉美,王金申.微生态肠内营养在结直肠癌患者围手术期的应用[J].中国现代普通外科进展,2007,10(4):324-327. 被引量:7
  • 4Tsukagoshi S. A new antiemetic ramosetron hydrochloride. Gan To Kagaku Ryoho, 1997,24:371-380.
  • 5Endo T, Minami M, Kitamura N, et al. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin release from the ferret isolated ileum. Res Commun Mol Pathol Pharmacol, 1999,104:145-155.
  • 6ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health Syst Pharm ,1999 ,56:729-764.
  • 7Rabasseda X. Ramosetron. A 5-HT3 receptor antagonist for the control of nausea and vomiting. Drugs Today (Barc), 2002,38:75-89.
  • 8Zeng XY, Wang AH, Liu YF, et al. Ramosetron for the management of chemotherapy-induced gastrotestinal events in patients with hematological malignancies. Methods Find Exp Clin Pharmacol, 2001,23 :191-195.
  • 9Noda K, Ikeda M, Yoshida O, et al. Clinical phase Ⅲ study of YM060 injection on anticancer drug,cisplatin-induced nausea and vomiting. Med Consult New Rem,1994,43:2241-2245.
  • 10Kang YK, Park YH, Ryoo BY, et al. Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron. J Int Med Res, 2002 ,30:220-229.

共引文献27

同被引文献35

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部